Search research articles
Contact Us
Filters
Showing results (251-260 of 291) with videos related to
Page
of 30
Sort By:
Plos One
|
November 13, 2015
Analytical Performance Characteristics of the Cepheid GeneXpert Ebola Assay for the Detection of Ebola Virus
Benjamin A Pinsky, Malaya K Sahoo, Johanna Sandlund, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 14, 2021
mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognition
Katharina Röltgen, Sandra C A Nielsen, Prabhu S Arunachalam, et al.
Emerging Infectious Diseases
|
October 20, 2020
High Dengue Burden and Circulation of 4 Virus Serotypes among Children with Undifferentiated Fever, Kenya, 2014-2017
Melisa M Shah, Bryson A Ndenga, Francis M Mutuku, et al.
Nature Communications
|
August 3, 2022
An intranasal ASO therapeutic targeting SARS-CoV-2
Chi Zhu, Justin Y Lee, Jia Z Woo, et al.
Biorxiv : the Preprint Server for Biology
|
May 20, 2021
Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variant
Venkata-Viswanadh Edara, Lilin Lai, Malaya K Sahoo, et al.
Genome Medicine
|
March 29, 2022
An 8-gene machine learning model improves clinical prediction of severe dengue progression
Yiran E Liu, Sirle Saul, Aditya Manohar Rao, et al.
Nature Communications
|
March 31, 2021
Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial
Prasanna Jagannathan, Jason R Andrews, Hector Bonilla, et al.
Science Advances
|
March 24, 2023
Magnitude and kinetics of the human immune cell response associated with severe dengue progression by single-cell proteomics
Makeda L Robinson, David R Glass, Veronica Duran, et al.
NPJ Vaccines
|
November 22, 2023
BA.5 bivalent booster vaccination enhances neutralization of XBB.1.5, XBB.1.16 and XBB.1.9 variants in patients with lung cancer
Rajesh M Valanparambil, Lilin Lai, Margaret A Johns, et al.
The Lancet. Infectious Diseases
|
February 3, 2025
The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variant
Mehul S Suthar, Kelly E Manning, Madison L Ellis, et al.
Page
of 30
Search research articles
Search
Showing results (251-260 of 291) with videos related to
Sort By:
Page
of 30
Plos One
|
November 13, 2015
Analytical Performance Characteristics of the Cepheid GeneXpert Ebola Assay for the Detection of Ebola Virus
Benjamin A Pinsky, Malaya K Sahoo, Johanna Sandlund, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 14, 2021
mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognition
Katharina Röltgen, Sandra C A Nielsen, Prabhu S Arunachalam, et al.
Emerging Infectious Diseases
|
October 20, 2020
High Dengue Burden and Circulation of 4 Virus Serotypes among Children with Undifferentiated Fever, Kenya, 2014-2017
Melisa M Shah, Bryson A Ndenga, Francis M Mutuku, et al.
Nature Communications
|
August 3, 2022
An intranasal ASO therapeutic targeting SARS-CoV-2
Chi Zhu, Justin Y Lee, Jia Z Woo, et al.
Biorxiv : the Preprint Server for Biology
|
May 20, 2021
Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variant
Venkata-Viswanadh Edara, Lilin Lai, Malaya K Sahoo, et al.
Genome Medicine
|
March 29, 2022
An 8-gene machine learning model improves clinical prediction of severe dengue progression
Yiran E Liu, Sirle Saul, Aditya Manohar Rao, et al.
Nature Communications
|
March 31, 2021
Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial
Prasanna Jagannathan, Jason R Andrews, Hector Bonilla, et al.
Science Advances
|
March 24, 2023
Magnitude and kinetics of the human immune cell response associated with severe dengue progression by single-cell proteomics
Makeda L Robinson, David R Glass, Veronica Duran, et al.
NPJ Vaccines
|
November 22, 2023
BA.5 bivalent booster vaccination enhances neutralization of XBB.1.5, XBB.1.16 and XBB.1.9 variants in patients with lung cancer
Rajesh M Valanparambil, Lilin Lai, Margaret A Johns, et al.
The Lancet. Infectious Diseases
|
February 3, 2025
The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variant
Mehul S Suthar, Kelly E Manning, Madison L Ellis, et al.
Page
of 30